Management and risk mitigation strategies for <i>FLT3</i> -ITD+ acute myeloid leukemia: clinical utilization of quizartinib

Authors

Institutions

Publication Details

Journal
Leukemia & lymphoma/Leukemia and lymphoma
Published
2026-05-30
DOI
https://doi.org/10.1080/10428194.2026.2676107
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Management and risk mitigation strategies for FLT3 -ITD+ acute myeloid leukemia: clinical utilization of quizartinib

Jeffrey Baron, Pamela J. Sung, Laurie Horsch, Eunice S. Wang
Leukemia & lymphoma/Leukemia and lymphoma
Acute Myeloid Leukemia Research
article

Management and risk mitigation strategies for FLT3 -ITD+ acute myeloid leukemia: clinical utilization of quizartinib

Jeffrey Baron, Pamela J. Sung, Laurie Horsch, Eunice S. Wang
article en

Abstract

No abstract available for this paper.
Leukemia & lymphoma/Leukemia and lymphoma
Roswell Park Comprehensive Cancer Center (US), Lake Erie College of Osteopathic Medicine (US)
Climate action
Openalex Percentile: Top 5%
Acute Myeloid Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.